IL15 and cancer: Our exploration into CAR and IL-15 engineered CD16Hi Vδ2 T cell therapy development revealed several areas for further interrogation to determine the potential of this population for cancer treatment, such as T cell memory status, in vivo polarization, immunogenicity, and CD16Hi Vδ2 T cell pool formation.